cdri 85-287 has been researched along with proadifen in 1 studies
Studies (cdri 85-287) | Trials (cdri 85-287) | Recent Studies (post-2010) (cdri 85-287) | Studies (proadifen) | Trials (proadifen) | Recent Studies (post-2010) (proadifen) |
---|---|---|---|---|---|
22 | 0 | 3 | 1,481 | 0 | 35 |
Protein | Taxonomy | cdri 85-287 (IC50) | proadifen (IC50) |
---|---|---|---|
Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 1.5849 | |
Aldehyde oxidase 1 | Rattus norvegicus (Norway rat) | 1.1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kon, OL; Ng, SC; Sim, KY; Teo, CC | 1 |
1 other study(ies) available for cdri 85-287 and proadifen
Article | Year |
---|---|
Synthesis of 2-(p-chlorobenzyl)-3-aryl-6-methoxybenzofurans as selective ligands for antiestrogen-binding sites. Effects on cell proliferation and cholesterol synthesis.
Topics: Benzofurans; Binding Sites; Binding, Competitive; Cell Division; Cell Line; Cholesterol; Estrogen Antagonists; Humans; Ligands; Receptors, Estrogen; Thymidine | 1992 |